A5054956896- Colorectal Cancer Treatments and Studies
- Neuroendocrine Tumor Research Advances
- Colorectal Cancer Surgical Treatments
- Cancer Treatment and Pharmacology
- Inflammatory Biomarkers in Disease Prognosis
- Cerebrospinal fluid and hydrocephalus
- Gastric Cancer Management and Outcomes
- Pediatric Urology and Nephrology Studies
- Fetal and Pediatric Neurological Disorders
- Radiopharmaceutical Chemistry and Applications
- Intracranial Aneurysms: Treatment and Complications
- Urinary Tract Infections Management
- Teratomas and Epidermoid Cysts
- Hematological disorders and diagnostics
- Lung Cancer Treatments and Mutations
- Colorectal and Anal Carcinomas
- Ferroptosis and cancer prognosis
- Ovarian cancer diagnosis and treatment
- Moyamoya disease diagnosis and treatment
- Neuroblastoma Research and Treatments
- Lung Cancer Research Studies
- Urinary Bladder and Prostate Research
- Blood disorders and treatments
- Genetic and Kidney Cyst Diseases
- Biomarkers in Disease Mechanisms
Istanbul Medipol University
2020-2025
Sağlık Bilimleri Üniversitesi
2024
University of Health Science
2024
Ümraniye Eğitim ve Araştırma Hastanesi
2024
Background/Objectives: The study aimed to compare the treatment effectiveness of patients with locally advanced rectal cancer undergoing standard neoadjuvant therapy or total therapy. It also sought identify prognostic factors for disease-free survival and overall parameters predictive pathological complete response. Materials Methods: A retrospective analysis was conducted on 239 diagnosed between 2016 2022 at several medical centers in Turkey. Clinical data, including chemoradiotherapy...
Moyamoya disease is a rare chronic progressive cerebrovascular disease.The etiology of moyamoya has not been established yet.If an underlying cause detected, called syndrome.A 27-year-old right-handed male was admitted to external medical center with recurrent severe headaches, vomiting, and seizures.He diagnosed prolactinoma as result cranial magnetic resonance imaging blood tests.After three months, he presented again headache left-sided weakness affecting both his arm leg.Head neck...
We aimed to compare FOLFIRI and bevacizumab with aflibercept in terms of overall survival (OS), progression-free (PFS) safety patients RAS-mutant metastatic colon cancer who progressed after first-line FOLFOX or XELOX treatment. This retrospective study included 243 from 15 different centres Turkey. The endpoints the were OS, PFS side effect outcomes. median age was 60 (21–85) years. Of enrolled study, 114 (46.9%) received 129 (53.1%) bevacizumab. Median OS 11.2 (95% CI: 9.1–13.2) months...
Regorafenib, an oral multikinase inhibitor, has improved survival in metastatic colorectal cancer (mCRC) patients who have progressed on standard therapies. Our study aimed to evaluate prognostic factors influencing regorafenib treatment and assess the optimal dosing regimen a real-life setting. We retrospectively analysed 263 with mCRC from multiple medical oncology clinics Turkey. Treatment responses for were evaluated using univariate multivariate analysis. Of patients, 120 male, 143...
Immune checkpoint inhibitors are drugs that included in the guidelines of hematological and solid cancer treatments, give highly effective results increase T cell functionality. However, these can cause immune-related adverse events resembling autoimmune diseases.A 50-year-old male patient was admitted to an external center with complaints chest pain dyspnea. Thoracic CT revealed a 97 × 58 mm mass left lung, diagnosis Small Cell Lung Cancer (SCLC) made by biopsy. The PET/CT performed for...
Background/Aim: Breast cancer is the second most common cause of cancer-related death in women worldwide. Predicting prognosis breast with very high mortality important terms disease treatment and increasing life expectancy. In our study, we aimed to examine importance some inflammatory markers scoring systems predicting patients who were hospitalized intensive care unit. Methods: This retrospective cohort study was conducted Department Medical Oncology Intensive Care Unit between 2014 2020....
Searchable abstracts of presentations at key conferences in endocrinology ISSN 1470-3947 (print) | 1479-6848 (online)
Searchable abstracts of presentations at key conferences in endocrinology ISSN 1470-3947 (print) | 1479-6848 (online)
Searchable abstracts of presentations at key conferences in endocrinology ISSN 1470-3947 (print) | 1479-6848 (online)
Searchable abstracts of presentations at key conferences in endocrinology ISSN 1470-3947 (print) | 1479-6848 (online)
Searchable abstracts of presentations at key conferences in endocrinology ISSN 1470-3947 (print) | 1479-6848 (online)
e13055 Background: We aimed to examine whether inflammatory markers and various risk scoring systems could be utilized predict the prognosis of breast cancer patients hospitalized in intensive care unit. Methods: In this retrospective cohort study, we evaluated 71 followed treated by Medical Oncology Department Medipol University Faculty Medicine who were admitted unit at any stage their treatment between 2014 2020. addition developed assess ICU, recorded calculated inflammation-related...